Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01FPX
|
|||
| Former ID |
DNC006545
|
|||
| Drug Name |
5-amino-2-p-tolyl-oxazole-4-carboxylic acid amide
|
|||
| Synonyms |
5-amino-2-(4-methylphenyl)-1,3-oxazole-4-carboxamide; CHEMBL382993; 5-amino-2-p-tolyl-oxazole-4-carboxylic acid amide; CTK6B8237; MolPort-000-894-518; SBB024037; BDBM50186628; STK351079; ZINC12394806; AKOS000313592; MCULE-2038651256
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H11N3O2
|
|||
| Canonical SMILES |
CC1=CC=C(C=C1)C2=NC(=C(O2)N)C(=O)N
|
|||
| InChI |
1S/C11H11N3O2/c1-6-2-4-7(5-3-6)11-14-8(9(12)15)10(13)16-11/h2-5H,13H2,1H3,(H2,12,15)
|
|||
| InChIKey |
RSMHDVYJLCPVNY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Evolution of the thienopyridine class of inhibitors of IkappaB kinase-beta: part I: hit-to-lead strategies. J Med Chem. 2006 May 18;49(10):2898-908. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.